Quince Therapeutics Inc. (NASDAQ: QNCX)
$0.76
+0.0100 ( +1.33% ) 51.0K
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.
Market Data
Open
$0.76
Previous close
$0.75
Volume
51.0K
Market cap
$32.41M
Day range
$0.75 - $0.79
52 week range
$0.63 - $1.70
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 82 | Nov 14, 2023 |
8-k | 8K-related | 13 | Oct 26, 2023 |
4 | Insider transactions | 1 | Oct 26, 2023 |
3 | Insider transactions | 2 | Oct 24, 2023 |
4 | Insider transactions | 1 | Oct 24, 2023 |
4 | Insider transactions | 1 | Oct 24, 2023 |
3 | Insider transactions | 2 | Oct 24, 2023 |
8-k | 8K-related | 13 | Oct 23, 2023 |
8-k | 8K-related | 13 | Sep 06, 2023 |
4 | Insider transactions | 1 | Sep 06, 2023 |